A phase I/II trial of Temodar in pediatric patients and young adults with high-risk or recurrent solid tumors
Phase of Trial: Phase I/II
Latest Information Update: 05 Apr 2007
At a glance
- Drugs Temozolomide (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- 05 Apr 2007 New trial record.